Skip to main content
2024 AAOMS 106th Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed <br><i>This session/event requires a ticket.</i>
Ticketed
This session/event requires a ticket.
In-person only<br><i>This session is offered in-person only.</i>
In-person only
This session is offered in-person only.
On-demand<br><i>On-demand session available beginning Sept. 9.</i>
On-demand
On-demand session available beginning Sept. 9.
Recorded<br><i>This session will be recorded and available beginning Sept. 30.</i>
Recorded
This session will be recorded and available beginning Sept. 30.
Sold Out<br><i>This ticketed session/event is sold out.</i>
Sold Out
This ticketed session/event is sold out.
2024 Oral Abstract Award
2024 Oral Abstract Award
Poster Icons
Poster Winner
Poster Winner
Back
Evaluation Video

Pathology

Head & Neck

OMS and Other Dental Specialists
Clinical Tracks

GP1d - Pathology and Head & Neck Track: Hot-off-the-Press and Abstract Session

Thursday, September 12, 2024
4:00 PM – 5:00 PM EDT
Location: Tangerine Ballroom WF2, Orange County Convention Center
CE: 1.0 CDE/CME

Recorded<br><i>This session will be recorded and available beginning Sept. 30.</i>

This session will review up to date information regarding pathologic conditions of great interest to oral and maxillofacial surgery practice. The nuances of MRONJ diagnosis, treatment, and postoperative complications; ameloblastoma diagnosis; and jaw sarcoma prognosis are discussed.

Learning Objectives:

At the conclusion of this presentation, participants should be able to:
  1. Discuss the risk of MRONJ in pediatric patients treated with antiresorptive medications.
  2. Discuss the use of BRAF V600E immunohistochemistry in the diagnosis of ameloblastomas of the jaws.
  3. Review the risk factors for infection recurrence following surgical resection of MRONJ.
  4. Discuss the prognostic factors associated with head and neck sarcomas.

Presentations:

  • 4:00 PM – 4:10 PM EDT
    Pediatric MRONJ Risk With Denosumab and Bisphosphonates

    Oral Abstract Presenter: Richard Foote

    Oral Abstract Presenter: Sasha Lasky, BS – Division of Plastic and Maxillofacial Surgery, Children's Hospital Los Angeles

    Co-Author: Tayla Moshal – Division of Plastic and Maxillofacial Surgery, Children's Hospital Los Angeles

    Co-Author: Pasha Shakoori, MD, DDS – Division of Plastic and Maxillofacial Surgery, Children’s Hospital Los Angeles

    Co-Author: Idean Roohani, BS – Division of Plastic and Maxillofacial Surgery, Children's Hospital Los Angeles

    Co-Author: Marah Jolibois, MS (she/her/hers) – Division of Plastic and Maxillofacial Surgery, Children's Hospital Los Angeles

    Co-Author: Simon Youn, MD DDS – LA General Medical Center

    Co-Author: Mark M. Urata, DDS, MD – Division of Plastic and Maxillofacial Surgery, Children’s Hospital Los Angeles

    Co-Author: Jeffrey A. Hammoudeh, DDS, MD – Division of Plastic and Maxillofacial Surgery, Children’s Hospital Los Angeles

  • 4:10 PM – 4:20 PM EDT
    Utility of BRAF V600E Immunohistochemistry in the Diagnosis of Mandibular Ameloblastomas

    Speaker: Yisi Daisy Ji, MD DMD (she/her/hers) – Providence Medical Center / HNSA

  • 4:20 PM – 4:30 PM EDT
    Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible

    Speaker: Joshua Lubek, DDS, MD – University of Maryland

  • 4:30 PM – 4:40 PM EDT
    Is Preoperative Serum Albumin Predictive of Adverse Outcomes in Head and Neck Cancer Surgery

    Speaker: Donita Dyalram, DDS, MD, FACS (she/her/hers) – University of Maryland

  • 4:40 PM – 4:50 PM EDT
    Alcohol and Head and Neck Cancer: Is There a Safer Way to Drink? An Observational Study of a Large National Cohort

    Oral Abstract Presenter: Alex Orchard, BDS MFDS RCS MSc CertMedEd DipSed MOralSurg – Guy's Hospital, London Bridge, United Kingdom

    Co-Author: Mark Gormley, BDS (Hons), MMEd, MSt, PhD, MOral Surg, FHEA, FDS(OS) RCSEd – University of Bristol

  • 4:50 PM – 5:00 PM EDT
    Q&A